1 Product identity
Ingredient risk
Contains restricted ingredients

M1D Andro Liquid

BrandLG SciencesNon-Nutrient/Non-Botanical Other (e.g. tea bag) 15 ingredients 1 banned DSLD #33299
Net contents: 6 oz.
Target: Adults and Children 4 years and above
DSLD entry: 2014-05-23
2 Ingredients (15)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)
3beta-Hydroxy-androst-5-ene-17-oneDHEABanned in ≥1 country
Androsta 3,5-Diene-7,17-Dione3-deoxy 7-oxo DHEABanned in ≥1 country
ResveratrolResveratrolConditionally Safe
WaterWater
GlycerolGlycerol
HPBCDHydroxypropyl beta-cyclodextrin
Citric AcidCitric Acid
N&A FlavorFlavor
Ca EDTAEDTA
K SorbatePotassium sorbate
Na BenzoateSodium Benzoate
SucraloseSucraloseConditionally Safe
Ace KAcesulfame potassium
SteviaStevia
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
DHEA  🇨🇦 🇬🇧 🇪🇺 🇦🇺 — Not approved for OTC sale as supplement.
3 Safety cross-reference
DHEA — Banned in ≥1 country
⚠ Hormonal: acne, hirsutism, voice deepening
⚠ May promote hormone-sensitive cancers
Resveratrol — Conditionally Safe
⚠ Estrogenic activity
⚠ CYP enzyme inhibition
Sucralose — Conditionally Safe
⚠ May affect gut microbiome
⚠ Heating may produce chlorinated compounds
4 Label claims
• All Other
5 Data source
DSLD ID33299
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-05-23
6 More from LG Sciences
View LG Sciences Safety Scorecard → 14 products
1-Andro Stenolone1-Androstenolone17-Pro AndroC2KEPI AndroEpic Fruit Punch
7 Cite this page
Vancouver
Pkhakadze G. M1D Andro Liquid — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 11]. Available from: https://supplement.ge/products/m1d-andro-liquid-33299/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG